Selected research
Market Structure
Global Endostatin Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Endostatin Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Endostatin Protein include Hengrui Pharma, ZYBio, Sigma-Aldrich, R&D Systems, Prospec, PeproTech, Novus Biologicals, MyBioSource and MedChem Express, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Endostatin Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endostatin Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endostatin Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endostatin Protein market size, projected growth trends, production technologies, key applications, and end-use industries.
Endostatin Protein Segment by Company
Hengrui Pharma
ZYBio
Sigma-Aldrich
R&D Systems
Prospec
PeproTech
Novus Biologicals
MyBioSource
MedChem Express
Innovative Research
Denovo Biopharma
BioLegend
Endostatin Protein Segment by Type
Natural Endostatin
Recombinant Endostatin
Endostatin Protein Segment by Application
Medical
Pharmaceuticals
Endostatin Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endostatin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endostatin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endostatin Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Endostatin Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endostatin Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endostatin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Endostatin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Natural Endostatin
- Recombinant Endostatin
Applications
- Medical
- Pharmaceuticals
Companies covered
- Hengrui Pharma
- ZYBio
- Sigma-Aldrich
- R&D Systems
- Prospec
- PeproTech
- Novus Biologicals
- MyBioSource
- MedChem Express
- Innovative Research
- Denovo Biopharma
- BioLegend
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Endostatin Protein Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Endostatin Protein Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Endostatin Protein Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Endostatin Protein Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Endostatin Protein Market Dynamics
- 2.1 Endostatin Protein Industry Trends
- 2.2 Endostatin Protein Industry Drivers
- 2.3 Endostatin Protein Industry Opportunities and Challenges
- 2.4 Endostatin Protein Industry Restraints
3 Endostatin Protein Market by Manufacturers
- 3.1 Global Endostatin Protein Revenue by Manufacturers (2021-2026)
- 3.2 Global Endostatin Protein Sales by Manufacturers (2021-2026)
- 3.3 Global Endostatin Protein Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Endostatin Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Endostatin Protein Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Endostatin Protein Manufacturers, Product Type & Application
- 3.7 Global Endostatin Protein Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Endostatin Protein Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Endostatin Protein Players Market Share by Revenue in 2025
- 3.8.3 2025 Endostatin Protein Tier 1, Tier 2, and Tier 3
4 Endostatin Protein Market by Type
- 4.1 Endostatin Protein Type Introduction
- 4.1.1 Natural Endostatin
- 4.1.2 Recombinant Endostatin
- 4.2 Global Endostatin Protein Sales by Type
- 4.2.1 Global Endostatin Protein Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Endostatin Protein Sales by Type (2021-2032)
- 4.2.3 Global Endostatin Protein Sales Market Share by Type (2021-2032)
- 4.3 Global Endostatin Protein Revenue by Type
- 4.3.1 Global Endostatin Protein Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Endostatin Protein Revenue by Type (2021-2032)
- 4.3.3 Global Endostatin Protein Revenue Market Share by Type (2021-2032)
5 Endostatin Protein Market by Application
- 5.1 Endostatin Protein Application Introduction
- 5.1.1 Medical
- 5.1.2 Pharmaceuticals
- 5.2 Global Endostatin Protein Sales by Application
- 5.2.1 Global Endostatin Protein Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Endostatin Protein Sales by Application (2021-2032)
- 5.2.3 Global Endostatin Protein Sales Market Share by Application (2021-2032)
- 5.3 Global Endostatin Protein Revenue by Application
- 5.3.1 Global Endostatin Protein Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Endostatin Protein Revenue by Application (2021-2032)
- 5.3.3 Global Endostatin Protein Revenue Market Share by Application (2021-2032)
6 Global Endostatin Protein Sales by Region
- 6.1 Global Endostatin Protein Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Endostatin Protein Sales by Region (2021-2032)
- 6.2.1 Global Endostatin Protein Sales by Region (2021-2026)
- 6.2.2 Global Endostatin Protein Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Endostatin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Endostatin Protein Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Endostatin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Endostatin Protein Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Endostatin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Endostatin Protein Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Endostatin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Endostatin Protein Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Endostatin Protein Revenue by Region
- 7.1 Global Endostatin Protein Revenue by Region
- 7.1.1 Global Endostatin Protein Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Endostatin Protein Revenue by Region (2021-2026)
- 7.1.3 Global Endostatin Protein Revenue by Region (2027-2032)
- 7.1.4 Global Endostatin Protein Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Endostatin Protein Revenue (2021-2032)
- 7.2.2 North America Endostatin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Endostatin Protein Revenue (2021-2032)
- 7.3.2 Europe Endostatin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Endostatin Protein Revenue (2021-2032)
- 7.4.2 Asia-Pacific Endostatin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Endostatin Protein Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Endostatin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Hengrui Pharma
- 8.1.1 Hengrui Pharma Company Information
- 8.1.2 Hengrui Pharma Business Overview
- 8.1.3 Hengrui Pharma Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Hengrui Pharma Endostatin Protein Product Portfolio
- 8.1.5 Hengrui Pharma Recent Developments
- 8.2 ZYBio
- 8.2.1 ZYBio Company Information
- 8.2.2 ZYBio Business Overview
- 8.2.3 ZYBio Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ZYBio Endostatin Protein Product Portfolio
- 8.2.5 ZYBio Recent Developments
- 8.3 Sigma-Aldrich
- 8.3.1 Sigma-Aldrich Company Information
- 8.3.2 Sigma-Aldrich Business Overview
- 8.3.3 Sigma-Aldrich Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sigma-Aldrich Endostatin Protein Product Portfolio
- 8.3.5 Sigma-Aldrich Recent Developments
- 8.4 R&D Systems
- 8.4.1 R&D Systems Company Information
- 8.4.2 R&D Systems Business Overview
- 8.4.3 R&D Systems Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 R&D Systems Endostatin Protein Product Portfolio
- 8.4.5 R&D Systems Recent Developments
- 8.5 Prospec
- 8.5.1 Prospec Company Information
- 8.5.2 Prospec Business Overview
- 8.5.3 Prospec Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Prospec Endostatin Protein Product Portfolio
- 8.5.5 Prospec Recent Developments
- 8.6 PeproTech
- 8.6.1 PeproTech Company Information
- 8.6.2 PeproTech Business Overview
- 8.6.3 PeproTech Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 PeproTech Endostatin Protein Product Portfolio
- 8.6.5 PeproTech Recent Developments
- 8.7 Novus Biologicals
- 8.7.1 Novus Biologicals Company Information
- 8.7.2 Novus Biologicals Business Overview
- 8.7.3 Novus Biologicals Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Novus Biologicals Endostatin Protein Product Portfolio
- 8.7.5 Novus Biologicals Recent Developments
- 8.8 MyBioSource
- 8.8.1 MyBioSource Company Information
- 8.8.2 MyBioSource Business Overview
- 8.8.3 MyBioSource Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 MyBioSource Endostatin Protein Product Portfolio
- 8.8.5 MyBioSource Recent Developments
- 8.9 MedChem Express
- 8.9.1 MedChem Express Company Information
- 8.9.2 MedChem Express Business Overview
- 8.9.3 MedChem Express Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 MedChem Express Endostatin Protein Product Portfolio
- 8.9.5 MedChem Express Recent Developments
- 8.10 Innovative Research
- 8.10.1 Innovative Research Company Information
- 8.10.2 Innovative Research Business Overview
- 8.10.3 Innovative Research Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Innovative Research Endostatin Protein Product Portfolio
- 8.10.5 Innovative Research Recent Developments
- 8.11 Denovo Biopharma
- 8.11.1 Denovo Biopharma Company Information
- 8.11.2 Denovo Biopharma Business Overview
- 8.11.3 Denovo Biopharma Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Denovo Biopharma Endostatin Protein Product Portfolio
- 8.11.5 Denovo Biopharma Recent Developments
- 8.12 BioLegend
- 8.12.1 BioLegend Company Information
- 8.12.2 BioLegend Business Overview
- 8.12.3 BioLegend Endostatin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 BioLegend Endostatin Protein Product Portfolio
- 8.12.5 BioLegend Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Endostatin Protein Value Chain Analysis
- 9.1.1 Endostatin Protein Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Endostatin Protein Production Mode & Process
- 9.2 Endostatin Protein Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Endostatin Protein Distributors
- 9.2.3 Endostatin Protein Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst